openPR Logo
Press release

Hemostats Market Poised to Hit $4.66 Billion by 2029 with Accelerating Growth Trends

10-07-2025 07:43 AM CET | Health & Medicine

Press release from: The Business Research Company

Hemostats Market

Hemostats Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Hemostats Market Size Growth Forecast: What to Expect by 2025?
In recent times, the hemostats market has experienced a significant expansion. It is forecasted that the market value will rise from $3.37 billion in 2024 to $3.56 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. The historical growth trend is linked to advancements in surgery, an increasing elderly population, expansion in cardiovascular surgeries, orthopedic uses, and the prevalence of chronic diseases and coagulation disorders.

How Will the Hemostats Market Size Evolve and Grow by 2029?
It is predicted that the size of the hemostats market will exhibit robust growth in the coming years, expanding to $4.66 billion in 2029 with a compound annual growth rate (CAGR) of 7.0%. The growth during this projected period can be linked to emergency readiness and the response to the pandemic, development in global healthcare facilities, increasing demand for minimally invasive surgeries, the widening use case in different specialities, and focus on biocompatibility. During the forecasted period, the major trends to look out for include product innovation, progression in hemostatic technologies, and emphasis on minimally invasive surgeries.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

What Drivers Are Propelling the Growth of Hemostats Market Forward?
The hemostat market is anticipated to expand due to a predicted rise in surgical procedures. Surgical procedures entail any form of invasive intervention used to examine or manage a disease or condition. Hemostats are crucial in these procedures as they help minimize blood loss during surgery. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a professional organization in Lebanon for certified plastic surgeons, reported an 11.2% overall surge in procedures performed by plastic surgeons in 2022, with over 14.9 million surgical and 18.8 million non-surgical procedures being carried out globally. Furthermore, there has been an uptick in both types of procedures since the previous survey, with surgical and non-surgical procedures recording a 16.7% and 7.2% increase respectively. As such, the rise in surgical procedures is fueling the expansion of the hemostat market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8226&type=smp

Which Emerging Trends Are Transforming the Hemostats Market in 2025?
A significant trend in the hemostats market is the progression of technology. Leading companies in this sector are making remarkable strides in innovating new technologies and conducting extensive research and development. For example, Baxter, an American healthcare firm, announced the release of PERCLOT Absorbable Hemostatic Powder in the United States in March 2022. PERCLOT is a self-absorbing hemostatic powder that, immediately prepared for usage, is crafted for patients with functioning coagulation and cater to mild bleeding incidents. The introduction of PERCLOT in the United States enables the providing of a comprehensive assortment of active and passive hemostatic products to surgeons for controlling bleeding and thereby enhances the quality of care available to their patients.

What Are the Key Segments in the Hemostats Market?
The hemostats market covered in this report is segmented -

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats
2) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products
3) By Formulation: Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats
4) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications

Subsegments:
1) By Thrombin-Based Hemostats: Topical Thrombin, Lyophilized Thrombin
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads, Granules
3) By Combination Hemostats: Thrombin And Gelatin Combinations, Thrombin And Collagen Combinations
4) By Gelatin-Based Hemostats: Gelfoam, Gelatin Sponge
5) By Collagen-Based Hemostats: Collagen Sheets, Collagen Powder

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8226&type=smp

Who Are the Key Players Shaping the Hemostats Market's Competitive Landscape?
Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

What Geographic Markets Are Powering Growth in the Hemostats Market?
North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8226

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemostats Market Poised to Hit $4.66 Billion by 2029 with Accelerating Growth Trends here

News-ID: 4210759 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Hemostats

Absorbable Hemostats Market Overview
In today's dynamic global economy, the absorbable hemostats market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain. 𝐆𝐞𝐭
Hemostats Market Insights, Forecast to 2031
A new Report by DataM Intelligence, titled "Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Hemostats market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Hemostats market has been growing significantly
Hemostats Market Size, Outlook, Overview 2024-2033
The hemostats market size has grown strongly in recent years. It will grow from $3.17 billion in 2023 to $3.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications. The hemostats market size is expected to see strong growth in
Hemostats Market worth $3.7 billion by 2028
Hemostats Market in terms of revenue was estimated to be worth $2.7 Billion in 2023 and is poised to reach $3.7 Billion by 2028, growing at a CAGR of 6.7% from 2023 to 2028 according to a new report by MarketsandMarkets. The significant growth in the number of hospitals and surgical centers is expected to support the growth of the hemostats market, as these are key end users of hemostats. The
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our